Bertrand Schwartz
- Molecular Biology top 10%
- Biotechnology top 0.5%
- Genetics top 5%
- Biomedical Engineering top 10%
- Immunology top 10%
- Co-authors
- Daniel SchermanRavi RangaraMichel F. BureauLluis M. MirDidier BranellecP. DelaèreJulie GehlDidier Rouy
- Topics
- Virus-based gene therapy research (9 papers)RNA Interference and Gene Delivery (7 papers)Viral Infectious Diseases and Gene Expression in Insects (4 papers)
- Partner nations
- FranceMoroccoUnited States
In The Last Decade
Bertrand Schwartz
16 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 97
- Molecular Biology 983
- Biotechnology 590
- Genetics 409
- Biomedical Engineering 322
- Immunology 221
Countries citing papers authored by Bertrand Schwartz
This map shows the geographic impact of Bertrand Schwartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertrand Schwartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertrand Schwartz more than expected).
Fields of papers citing papers by Bertrand Schwartz
This network shows the impact of papers produced by Bertrand Schwartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertrand Schwartz. The network helps show where Bertrand Schwartz may publish in the future.
Co-authorship network of co-authors of Bertrand Schwartz
This figure shows the co-authorship network connecting the top 25 collaborators of Bertrand Schwartz. A scholar is included among the top collaborators of Bertrand Schwartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bertrand Schwartz. Bertrand Schwartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 50 | |
| 3 | 79 | |
| 4 | A phase I study of BAY 43-9006, a novel Raf kinase and VEGFR inhibitor, in combination with taxotere in patients with advanced, solid tumors | 4 |
| 5 | 20 | |
| 6 | 146 | |
| 7 | 5 | |
| 8 | 6 | |
| 9 | High-efficiency gene transfer into skeletal muscle mediated by electric pulsesbreakdown → | 749 |
| 10 | 147 | |
| 11 | 198 | |
| 12 | 6 | |
| 13 | 42 | |
| 14 | 61 | |
| 15 | 27 | |
| 16 | 38 |
About Bertrand Schwartz
Bertrand Schwartz is a scholar working on Biotechnology, Genetics and Physiology, having authored 16 papers that have together received 1.6k indexed citations. Recurring topics across this work include Virus-based gene therapy research (9 papers), RNA Interference and Gene Delivery (7 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). The work is most often cited by research in Biotechnology (590 citations), Genetics (409 citations) and Molecular Biology (983 citations). Bertrand Schwartz has collaborated with scholars based in France, Morocco and United States. Frequent co-authors include Daniel Scherman, Ravi Rangara, Michel F. Bureau, Lluis M. Mir, Didier Branellec, P. Delaère, Julie Gehl, Didier Rouy, Jean‐Michel Caillaud and Marc Frederic. Their work appears in journals such as Proceedings of the National Academy of Sciences, Circulation Research and Annals of Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.